TotalMarketCap

Sana Biotechnology

SANANasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$697.510 M

$2.33 -8.98%

Close of 6 Nov 2026

As of 6 Nov 2026, Sana Biotechnology (SANA) has a market capitalization of $697.5M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$244.2M

Loss-making

Shares outstanding

299,634,951

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #50Prime MedicinePRME$806.2M
  2. #51Cullinan TherapeuticsCGEM$704.0M
  3. #52Sana BiotechnologySANA$697.5M
  4. #53Solid BiosciencesSLDB$686.4M
  5. #54Attovia TherapeuticsATTO$684.1M

What if Sana Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$94,323.94

Per share 40,482× higher

Bitcoin $1.53T

$5,103.70

Per share 2,190× higher

Apple $5.02T

$16,754.98

Per share 7,191× higher

Or at a round number

$1.00B$2.00B$5.00B$10.0B

Where these numbers come from

Share counts and financials for Sana Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.